Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer


Dead | Dead

Total Raised


About Synbody Biotechnology

Synbody Biotechnology (SBI) is a biotechnology company based on a synthetic antibody, or Synbody, technology. Synbodies change the field of high affinity, high specificity therapeutic agents by creating antibody-like function from small purely synthetic peptides. It is SBI's mission to leverage the Synbody technology to create a pipeline of human therapeutics across multiple therapeutic areas. SBI seeks to realize the opportunity for synbodies as human therapeutics through a combined strategy comprising corporate partnerships, out-licensing agreements and in-house development.

Synbody Biotechnology Headquarter Location

400 Farmington Ave.

Farmington, Connecticut, 06030,

United States


Latest Synbody Biotechnology News

Synbody Biotechnology Raises $250K from Connecticut Innovations

Dec 24, 2012

Published On December 24, 2012 | Synbody Biotechnology Inc. (SBI) , a Farmigton, CT-based early-stage biotechnology company, has raised $250k from Connecticut Innovations . This investment was preceded by an initial investment of $750k that CI made through its Seed Investment Fund in March (read here ). Led by president Paul Hallenbeck, Ph.D., and vice president of research and development and co-founder Kevin Burroughs, Ph.D., Synbody focuses on advancing a novel drug discovery platform that utilizes unstructured, synthetically produced peptides to generate synthetic antibodies, “synbodies”, novel ligands that bind with specificity to any target of interest. In therapeutics, Synbody technology, which was developed at Arizona State University (ASU) and supported with over $10m in funding to date, has the potential to help researchers develop treatments for cancer, diabetes, and cardiovascular, central nervous system and infectious diseases. The company, which relocated to Connecticut from Pennsylvania, has developed collaborations with the University of Connecticut and Hartford Hospital. It is participating in the University of Connecticut’s Technology Incubator Program (TIP) and has laboratory operations in incubator space at the University of Connecticut Health Center. FinSMEs

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Synbody Biotechnology

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Synbody Biotechnology is included in 1 Expert Collection, including Pharma Startups.


Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.